These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25487691)

  • 21. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulation of renal gene expression using oligonucleotides.
    Lakhia R; Mishra A; Patel V
    Methods Cell Biol; 2019; 154():109-120. PubMed ID: 31493813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
    Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy.
    Kuehl U; Lassner D; Gast M; Stroux A; Rohde M; Siegismund C; Wang X; Escher F; Gross M; Skurk C; Tschoepe C; Loebel M; Scheibenbogen C; Schultheiss HP; Poller W
    Circ Heart Fail; 2015 May; 8(3):605-18. PubMed ID: 25761932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNAs in Diabetic Kidney Disease.
    Chung AC
    Adv Exp Med Biol; 2015; 888():253-69. PubMed ID: 26663187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic nephropathy: MiR-23b protects against fibrosis in diabetic nephropathy.
    Carney EF
    Nat Rev Nephrol; 2016 Apr; 12(4):197. PubMed ID: 26898629
    [No Abstract]   [Full Text] [Related]  

  • 29. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway.
    Shahni R; Czajka A; Mankoo BS; Guvenel AK; King AJ; Malik AN
    Int J Biochem Cell Biol; 2013 Mar; 45(3):626-35. PubMed ID: 23220173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR‑142‑3p promotes osteoblast differentiation by modulating Wnt signaling.
    Hu W; Ye Y; Zhang W; Wang J; Chen A; Guo F
    Mol Med Rep; 2013 Feb; 7(2):689-93. PubMed ID: 23229013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy.
    Zhou J; Peng R; Li T; Luo X; Peng H; Zha H; Yin P; Wen L; Zhang Z
    Gene; 2013 Sep; 527(2):456-61. PubMed ID: 23860321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA regulation in renal pathophysiology.
    Hou J; Zhao D
    Int J Mol Sci; 2013 Jun; 14(7):13078-92. PubMed ID: 23799361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway.
    Bu Q; Fang Y; Cao Y; Chen Q; Liu Y
    Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
    Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
    Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA cascade in diabetic kidney disease: Big impact initiated by a small RNA.
    Kato M; Natarajan R
    Cell Cycle; 2009 Nov; 8(22):3613-4. PubMed ID: 19884793
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary microRNA in Diabetic Kidney Disease: A Literature Review.
    Lee CC; Chen CC; Hsu CK; Chen YT; Chen CY; Yang KJ; Hung MJ; Wu IW
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mechanisms of protein synthesis in diabetic nephropathy--role of mRNA translation.
    Kasinath BS; Mariappan MM; Sataranatarajan K; Lee MJ; Ghosh Choudhury G; Feliers D
    Rev Endocr Metab Disord; 2008 Dec; 9(4):255-66. PubMed ID: 18654857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior.
    Ibrahim SA; Hassan H; Götte M
    Biochim Biophys Acta; 2014 Aug; 1840(8):2609-20. PubMed ID: 24462576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells.
    Takahashi M; Contu VR; Kabuta C; Hase K; Fujiwara Y; Wada K; Kabuta T
    RNA Biol; 2017 Nov; 14(11):1534-1543. PubMed ID: 28277980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.